Pascal Soriot at AstraZeneca's investor day (AstraZeneca)

With $5B in Chi­na sales, As­traZeneca dou­bles down on Chi­nese bio­phar­ma in­no­va­tion

CAM­BRIDGE, UK — As­traZeneca said it will con­tin­ue to be the con­duit for shar­ing Chi­nese in­no­va­tion with the rest of the world, but will es­tab­lish a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.